| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 04/26/2006 | CN1253449C Indolylmaleimide derivatives as protein kinase C inibitors |
| 04/26/2006 | CN1253441C Protease inhibitors |
| 04/26/2006 | CN1253440C New iso quinoline compound with HIV-1 resisting activity |
| 04/26/2006 | CN1253435C Aryl oxime-piperazines useful as CCR5 antagonists |
| 04/26/2006 | CN1253220C Intradermal delivery of vaccines and gene therapeutic agents via microcannula |
| 04/26/2006 | CN1253209C Heat-resistant lyophilized protectant of lyophilized vaccine for henpox and preparing process thereof |
| 04/26/2006 | CN1253207C Split enveloped virus preparation |
| 04/26/2006 | CN1253206C Method for obtaining antigenic aggregates and use thereof in formulations |
| 04/26/2006 | CN1253205C 疫苗 Vaccine |
| 04/26/2006 | CN1253185C Chinese medicine compound preparation for preventing and inhibiting infectious bacteria and virus and its producing method |
| 04/26/2006 | CN1253175C Medicinal composition, its preparation method and use |
| 04/26/2006 | CN1253170C Chinese medicine preparation for treating hepatitis and its preparing and detecting method |
| 04/26/2006 | CN1253158C Luminescent bio-element and preparation process thereof |
| 04/26/2006 | CN1253154C Method for preparing cefathiamidine freeze-dried sterile raw material medicine |
| 04/26/2006 | CN1253152C Single particle nano-garlicin micro-capsule, and its preparation method |
| 04/25/2006 | US7034150 Processes for the preparation of carbapenem-type antibacterial agents |
| 04/25/2006 | US7034142 Method to improve translation of polypeptides by using untranslated regions from heat-shock proteins |
| 04/25/2006 | US7034141 The packaging systems are based on the expression of split-helper functions by coinfecting cells with recombinant vectors, such as recombinant poxvirus vectors |
| 04/25/2006 | US7034131 Antibody therapy; immobilization |
| 04/25/2006 | US7034109 Intracellular delivery of biological effectors |
| 04/25/2006 | US7034108 Mimotopes of hypervariable region 1 of the E2 glycoprotein of HCV and uses thereof |
| 04/25/2006 | US7034057 Controlling tumor necrosis factor; antiinflamamtory agents, autoimmune disease |
| 04/25/2006 | US7034049 3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents |
| 04/25/2006 | US7034043 Cell adhesion inhibitors |
| 04/25/2006 | US7034031 Modulators of TNF-α signaling |
| 04/25/2006 | US7034030 Pyralopyridines, process for their preparation and use as therapeutic compounds |
| 04/25/2006 | US7034028 Treatment of inflammatory disorders |
| 04/25/2006 | US7034025 Administering to a mammal an effective dose of a cysteine derivatives containing heteroaromatic group for the treatment of arterial tension, embryogenesis, oncogenesis, diabetes, cell proliferation, and other diseases |
| 04/25/2006 | US7034022 Proteases, kinases enzyme inhibitors; cardiovascular disorders; central nervous system disorders; antiinflammatrory agents; bone disorders; infections |
| 04/25/2006 | US7034019 Prodrugs of HIV replication inhibiting pyrimidines |
| 04/25/2006 | US7034014 Phosphonate compounds |
| 04/25/2006 | US7034006 Use of lipid conjugates in the treatment of disease |
| 04/25/2006 | US7034005 Use of macrolide derivatives such as 6,15,16-Trioxatricyclo(10.2.1.11,4) hexadecane, erythromycin derivative |
| 04/25/2006 | US7033997 Use of natriuretic peptides as antibiotically active substances for the treatment of bacterial infections |
| 04/25/2006 | US7033805 Contains amino acid motifs of a serine proteinase, a nucleotide triphosphatase (NTPase), and an RNA helicase. |
| 04/25/2006 | US7033604 Composition for topical administration |
| 04/25/2006 | US7033599 Injectable compositions for the controlled delivery of pharmacologically active compound |
| 04/25/2006 | US7033594 Method of treatment using ligand-immunogen conjugates |
| 04/25/2006 | US7033578 Antimycotic nail varnish composition |
| 04/25/2006 | US7033575 Delivery of physiologically active compounds through an inhalation route |
| 04/25/2006 | CA2410745C Process for converting the carbonyl function in position 4" of the cladinose unit of an aza-macrolide into an amine derivative |
| 04/20/2006 | WO2006042324A2 Antifungal composition applicable to body tissue, preferably nails |
| 04/20/2006 | WO2006042104A2 Calixarene-based peptide conformation mimetics, methods of use, and methods of making |
| 04/20/2006 | WO2006041192A1 Medicinal compositions containing apoptosis inducer |
| 04/20/2006 | WO2006040893A1 Novel antimicrobial medicine |
| 04/20/2006 | WO2006040643A2 Polymorphic forms of efavirenz and processes for their preparation |
| 04/20/2006 | WO2006040558A1 Substituted adenines and the use thereof |
| 04/20/2006 | WO2006040451A2 Novel 9h-pyrido[2,3-b]indole derivatives serving as cdk and gsk3 inhibitors, method for the preparation thereof, and the pharmaceutical compositions containing such compounds |
| 04/20/2006 | WO2006021888A3 Dihydrofolate reductase inhibition by epigallocatechin gallate compounds |
| 04/20/2006 | WO2006018609A3 Anti-inflammatory agents |
| 04/20/2006 | WO2004064732A3 The use of bacterial phage-associated lysing proteins for preventing and treating bacterial infections in humans, animals and fowl |
| 04/20/2006 | US20060084809 Compounds as PDE IV and TNF-inhibitors |
| 04/20/2006 | US20060084667 New derivatives of amidines, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
| 04/20/2006 | US20060084661 IL-8 receptor antagonists |
| 04/20/2006 | US20060084646 Method of preparing alkylated salicylamides via a dicarboxylate intermediate |
| 04/20/2006 | US20060084641 IL-8 receptor antagonists |
| 04/20/2006 | US20060084631 Antimicrobial charged polymers that exhibit resistance to lysosomal degradation during kidney filtration and renal passage, compositions and method of use thereof |
| 04/20/2006 | US20060084627 Synergistic interaction of abacavir and alovudine |
| 04/20/2006 | US20060084624 beta-L-2'-deoxy-nucleosides for the treatment of hepatitis B |
| 04/20/2006 | US20060084618 Adiponectin promoter and use thereof |
| 04/20/2006 | US20060084613 Dipeptide enzyme inhibitor; antiinflammatory agents; autoimmune disease; wound healing agents |
| 04/20/2006 | US20060084593 Anti-hiv composition, production method thereof and medicament |
| 04/20/2006 | US20060084118 Lymphocytes; transcription factors; interferons; diagnosis of autoimmune disease such as lupus |
| 04/20/2006 | US20060083792 Utilizing nanocrystalline silver metal, alloy or compound for localized tissue infections; reducing side effects; limiting overuse of antibiotics |
| 04/20/2006 | US20060083784 Amorphous pharmaceutical compositions |
| 04/20/2006 | US20060083778 Controlled release compositions of estradiol metabolites |
| 04/20/2006 | US20060083759 Stabilization of the profile of release of active substances from a formulation |
| 04/20/2006 | US20060083755 Vaccine for feline infectious peritonitis |
| 04/20/2006 | US20060083752 Novel compounds |
| 04/20/2006 | US20060083740 By modulating the expression of mutant and wild type CD83 gene products produced in a mammal; regulation of T cell and dendritic cell activity; antibodies |
| 04/20/2006 | US20060083731 Use of an enzyme for the manufacture of an agent for controlling bacterial infection |
| 04/20/2006 | US20060083686 Therapeutic agent for ulcerative colitis |
| 04/20/2006 | US20060083684 Method of radio-labelling biomolecules |
| 04/20/2006 | US20060083676 For marking and identifying metabotropic glutamate receptor sites and for imaging an organ; in particular non-competitive mGlu1 receptor ligands |
| 04/20/2006 | DE102004049223A1 Zubereitung zum Impfen, Impfverfahren und Verwendung einer Impf-Zubereitung Preparation for seeding, seeding and use of a vaccine preparation |
| 04/20/2006 | CA2583092A1 Antiangiogenic calixarene-based peptide mimetics |
| 04/20/2006 | CA2581663A1 Novel antimicrobial medicament |
| 04/20/2006 | CA2581493A1 Taste-masking pharmaceutical compositions |
| 04/19/2006 | EP1647545A1 Antiviral protease inhibitors |
| 04/19/2006 | EP1647281A2 Polynucleotide vaccine formula for treating horse diseases |
| 04/19/2006 | EP1647276A1 Use of taurolidine formulations for the intramammary treatment of mastitis |
| 04/19/2006 | EP1647256A1 Dendritic cell infiltrativity activating composition and immune activator |
| 04/19/2006 | EP1647188A2 A method of controlling fungal pathogens, and agents useful for same |
| 04/19/2006 | EP1646646A1 Antibiotic 107891, its factors a1 and a2, pharmaceutically acceptable salts and compositions, and use thereof. |
| 04/19/2006 | EP1646644A2 Posh interacting proteins and related methods |
| 04/19/2006 | EP1646642A2 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease |
| 04/19/2006 | EP1646638A2 11-12 bicyclic erythromycin derivatives |
| 04/19/2006 | EP1646630A1 Oxazolidinone antibiotics and derivatives thereof |
| 04/19/2006 | EP1646629A2 Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereof |
| 04/19/2006 | EP1646610A1 Tetrahydrocarbazole derivatives and their pharmaceutical use |
| 04/19/2006 | EP1646401A2 Specific human antibodies |
| 04/19/2006 | EP1646399A2 Pharmaceutical compositions of antithrombin iii for the treatment of retroviral diseases. |
| 04/19/2006 | EP1646392A2 7 and 8 membered heterocyclic cyclopentyl benzylamide modulators of chemokine receptor activity |
| 04/19/2006 | EP1646371A2 Antiviral compounds and methods |
| 04/19/2006 | EP1556371B1 Benzimidazole derivatives and their use as prodrugs of proton pump inhibitor |
| 04/19/2006 | EP1448564B1 Substituted indolizine-like compounds and methods of use |
| 04/19/2006 | EP1397384B1 Antimicrobially active peptide |
| 04/19/2006 | EP1383736A4 Peptide deformylase inhibitors |
| 04/19/2006 | EP1383729A4 Peptide deformylase inhibitors |
| 04/19/2006 | EP1373478B1 Attenuated live vaccine |